EichorEICHOR
Study identifier: NCT06250062 Synced from ClinicalTrials.gov · August 03, 2026
● Completed

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

Condition: Ankylosing Spondylitis  ·  Sponsor: Shanghai Junshi Bioscience Co., Ltd.

PhasePhase 2
Planned participants265
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (38)

Beijing Chao-yang Hospital,Capital Medical UniversityBeijing, Beijing Municipality, China
Jilin Province People's HospitalJilin City, Changchun, China
Zhongshan Hospital Xiamen UniversityXiamen, Fujian, China
The First Affiliated Hospital of Xiamen UniversityXiamen, Fujian, China
Gansu Provincial HospitalLanzhou, Gansu, China
Dongguan People's HospitalDongguan, Guangdong, China
Sun Yat-sen Memorial HospitalGuangzhou, Guangdong, China
Guangdong Provincial People's HospitalGuangzhou, Guangdong, China
Zhujiang Hospital of Southren Medical UniversityGuangzhou, Guangdong, China
The Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, Guangdong, China
Huizhou Central People's HospitalHuizhou, Guangdong, China
Jieyang People's HospitalJieyang, Guangdong, China

+ 26 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →